AstraZeneca's blockbuster lung cancer drug boosts survival rates among patients, pharma giant says
Daily Mail - 2024-04-05T20:50:39.000Z

In a shot in the arm for the FTSE 100 group, a trial revealed that Imfinzi showed promise in treating highly aggressive small cell lung cancer. Read this story